Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

Add To Watchlist

Bullboard (TSX:SVA)

View:

Comment by Jf4270393on Apr 09, 2024 12:19pm

RE:RE:Can SVA'S Cell Pouch lead to weight loss??

Perhaps Cell pouch used for weight gain would elevate the share price....

148

Discussion

Post by hoffbagon Apr 02, 2024 6:27pm

Good release ?

I wish I was smart and knew why they weren't getting more support from the market. Their immunosuppressive news seems to be a big deal to me.

158

Level Up Your Trading with BMO InvestorLine’s Enhanced Features

posted Nov 23, 2024 9:00am by Bank of Montreal

Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more

Post by rixpixon Apr 02, 2024 4:06pm

PEOPLE ALWAYS COMPLAIN no matter what.

Many people complain because apparently companies (such as SVA) don't give investors updates. Then when companies issue an update (like today) people get upset because the update didn't ...more

285

(0)
•••

Post by PressReleaseon Apr 02, 2024 7:01am

New Press Release - Sernova Provides Positive Clinical and Platform Portfolio Update

(TheNewswire)Type 1 diabetes (T1D) Cohort 2 patient data demonstrates favorable islet engraftment and long-term survival of human donor islets in the Cell PouchFirst treated Cohort 1 patient in the T1D clinical trial to celebrate four years of insulin independence and normalized HbA1cWith recent...read article.

Comment by LiquidRealityon Mar 23, 2024 4:04am

RE:RE:Follow the money?

Doesn't matter. What is done is done. More importantly is they are going to need money soon so a financing has got to be coming, and I would most assuredly beleive it will be at a price a lot ...more

330

Discussion